Cite
HARVARD Citation
Campani, C. et al. (n.d.). Time-varying mHAP III is the most accurate score in predicting survival in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE). Digestive and liver disease. pp. e6-. [Online].